In terms of metabolic phenotypes, dyslipidemia and impaired glucose metabolism represent the two core hallmarks of IR: reduced insulin-mediated suppression of lipolysis leads to elevated circulating triglyceride (TG) levels, while diminished insulin-mediated glucose uptake in the muscles and liver results in increased fasting blood glucose (FBG) levels. This evidence concerns the gene INS and metabolic syndrome.